Market Cap ₹946 Cr.
Stock P/E 35.0
P/B 2.4
Current Price ₹241.5
Book Value ₹ 101.7
Face Value 10
52W High ₹274.4
Dividend Yield 0%
52W Low ₹ 171
JG Chemicals Limited, part of the BDJ Group, is a leading manufacturer of Zinc Oxide in India. Established in 1975, the company has grown to become one of the top producers globally, with a production capacity of 60,000 MTPA of Zn chemicals. Promoted by the Jhunjhunwala family, who have been influential in various industries for over 90 years. They cater to over 300 customers worldwide, serving industries like rubber, ceramics, paints and coatings, pharmaceuticals, cosmetics, electronics, batteries, agro-chemicals, fertilizers, specialty chemicals, lubricants, oil and gas, and animal feed. JG Chemicals is known for its commitment to quality and innovation. Their R&D team works closely with customers to develop tailor-made products. The company has installed a dedicated production line at its Naidupeta plant to produce Zinc Oxide of various grades, meeting GMP requirements and catering to the pharmaceutical industry in particular.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Mar 2023 | Mar 2024 |
---|---|---|
Net Sales | 194 | 181 |
Other Income | 3 | 3 |
Total Income | 198 | 184 |
Total Expenditure | 179 | 164 |
Operating Profit | 19 | 20 |
Interest | 2 | 1 |
Depreciation | 1 | 1 |
Exceptional Income / Expenses | 0 | 0 |
Profit Before Tax | 16 | 18 |
Provision for Tax | 4 | 5 |
Profit After Tax | 12 | 14 |
Adjustments | -0 | -1 |
Profit After Adjustments | 11 | 13 |
Adjusted Earnings Per Share | 3.6 | 3.3 |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|
Net Sales | 250 | 339 | 399 | 435 | 613 | 785 | 375 |
Other Income | 1 | 3 | 8 | 7 | 10 | 11 | 6 |
Total Income | 251 | 343 | 408 | 442 | 623 | 796 | 382 |
Total Expenditure | 229 | 296 | 380 | 393 | 556 | 710 | 343 |
Operating Profit | 22 | 47 | 27 | 49 | 67 | 85 | 39 |
Interest | 6 | 6 | 6 | 5 | 7 | 5 | 3 |
Depreciation | 2 | 2 | 2 | 2 | 3 | 3 | 2 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 14 | 38 | 19 | 41 | 57 | 77 | 34 |
Provision for Tax | 5 | 13 | 5 | 12 | 14 | 20 | 9 |
Profit After Tax | 9 | 25 | 14 | 29 | 43 | 57 | 26 |
Adjustments | 0 | -2 | -1 | -5 | -3 | -2 | -1 |
Profit After Adjustments | 9 | 23 | 13 | 23 | 40 | 55 | 24 |
Adjusted Earnings Per Share | 2.9 | 7.3 | 4.1 | 7.4 | 12.6 | 17.3 | 6.9 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 28% | 25% | 26% | 0% |
Operating Profit CAGR | 27% | 47% | 31% | 0% |
PAT CAGR | 33% | 60% | 45% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 32% | 31% | 35% | 34% |
ROCE Average | 31% | 30% | 31% | 30% |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|
Shareholder's Funds | 31 | 54 | 85 | 108 | 153 | 208 |
Minority's Interest | 0 | 2 | 5 | 11 | 4 | 6 |
Borrowings | 14 | 8 | 6 | 5 | 6 | 7 |
Other Non-Current Liabilities | 1 | 6 | 0 | 0 | 0 | 1 |
Total Current Liabilities | 56 | 56 | 53 | 85 | 102 | 77 |
Total Liabilities | 102 | 126 | 149 | 210 | 264 | 298 |
Fixed Assets | 14 | 14 | 21 | 23 | 22 | 35 |
Other Non-Current Assets | 1 | 2 | 10 | 11 | 18 | 6 |
Total Current Assets | 87 | 110 | 119 | 176 | 224 | 256 |
Total Assets | 102 | 126 | 149 | 210 | 264 | 298 |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 0 | 1 | 1 | 5 | 6 |
Cash Flow from Operating Activities | -14 | 19 | 41 | -7 | 7 | 31 |
Cash Flow from Investing Activities | -6 | -2 | -11 | -6 | -5 | -5 |
Cash Flow from Financing Activities | 18 | -16 | -30 | 17 | -0 | -29 |
Net Cash Inflow / Outflow | -1 | 1 | -0 | 4 | 1 | -2 |
Closing Cash & Cash Equivalent | 0 | 1 | 1 | 5 | 6 | 4 |
# | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 2.91 | 7.27 | 4.08 | 7.39 | 12.61 | 17.32 |
CEPS(Rs) | 3.43 | 8.58 | 4.99 | 9.82 | 14.44 | 18.99 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 9.71 | 16.98 | 26.78 | 34.2 | 48.11 | 65.47 |
Core EBITDA Margin(%) | 8.31 | 12.74 | 4.81 | 9.65 | 9.25 | 9.45 |
EBIT Margin(%) | 8.04 | 13.13 | 6.4 | 10.69 | 10.49 | 10.46 |
Pre Tax Margin(%) | 5.79 | 11.32 | 4.79 | 9.46 | 9.37 | 9.78 |
PAT Margin (%) | 3.67 | 7.43 | 3.49 | 6.62 | 7.04 | 7.24 |
Cash Profit Margin (%) | 4.35 | 8.02 | 3.96 | 7.15 | 7.47 | 7.68 |
ROA(%) | 8.96 | 22.14 | 10.15 | 16.03 | 18.19 | 20.21 |
ROE(%) | 29.77 | 59.59 | 20.1 | 29.78 | 33.03 | 31.53 |
ROCE(%) | 21.63 | 44.86 | 21.03 | 29.05 | 29.93 | 31.28 |
Receivable days | 53.02 | 48.06 | 47.07 | 58.59 | 54.96 | 48.94 |
Inventory Days | 50.52 | 40.77 | 39.65 | 39.48 | 40.77 | 44.69 |
Payable days | 5.26 | 5.56 | 4.36 | 5.38 | 4.6 | 3.94 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.25 | 0.15 | 0.13 | 0.16 | 0.14 | 0.12 |
EV/Core EBITDA(x) | 2.9 | 1.12 | 1.93 | 1.44 | 1.3 | 1.14 |
Net Sales Growth(%) | 0 | 35.75 | 17.67 | 8.99 | 40.78 | 28.03 |
EBIT Growth(%) | 0 | 121.69 | -42.65 | 82.01 | 38.12 | 27.66 |
PAT Growth(%) | 0 | 175.12 | -44.69 | 106.4 | 49.75 | 31.69 |
EPS Growth(%) | 0 | 149.94 | -43.84 | 80.9 | 70.68 | 37.34 |
Debt/Equity(x) | 2.02 | 0.96 | 0.62 | 0.69 | 0.62 | 0.34 |
Current Ratio(x) | 1.57 | 1.98 | 2.23 | 2.07 | 2.2 | 3.34 |
Quick Ratio(x) | 0.95 | 1.24 | 1.38 | 1.49 | 1.33 | 1.99 |
Interest Cover(x) | 3.57 | 7.25 | 3.96 | 8.73 | 9.42 | 15.33 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 |
# | Mar 2024 |
---|---|
Promoter | 70.99 |
FII | 6.22 |
DII | 3.16 |
Public | 19.62 |
Others | 0 |
Total | 100 |
# | Mar 2024 |
---|---|
Promoter | 2.78 |
FII | 0.24 |
DII | 0.12 |
Public | 0.77 |
Others | 0 |
Total | 3.92 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About